Cancer, aging and immune reconstitution

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 9, 2013, Pages 1310-1324

  Zanussi, Stefania ^a   Serraino, Diego ^a   Dolcetti, Riccardo ^a   Berretta, Massimiliano ^a   De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Aging; B lymphocytes; Cancer; Dendritic cells; Epidemiology; Immune reconstitution; Immune system; Immunotherapy; Inflammaging; Monocytes macrophages; NK cells; T lymphocytes

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD40 LIGAND; CD57 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; IPILIMUMAB; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; RECOMBINANT INTERLEUKIN 7; SOMATOMEDIN C; STAT3 PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AGING; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; COLON CANCER; DENDRITIC CELL; GENETIC POLYMORPHISM; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RECONSTITUTION; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MACROPHAGE; METASTATIC MELANOMA; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW (TOPIC); T LYMPHOCYTE; TUMOR GROWTH; IMMUNOLOGY; NEOPLASMS;

AGING; HUMANS; NEOPLASMS;

EID: 84888223522     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113136660348     Document Type: Article

References (229)

1. Gruver, A.; Hudson, L.L.; Sempowski GD. Immunosenescence of aging. J. Pathol., 2007, 211, 144-156.
2. Pawelec, G.; Larbi, A. Immunity and aging in man: Annual Review 2006/2007. Exp Gerontol., 2008, 43(1), 34-38.
3. Weiskopf, D.; Weinberger, B.; Grubeck-Loebenstein, B. The aging of the immune system. Transplant Int., 2009, 1041-1050.
4. Hakim, F.T.; Gress, R.E. Immunosenescence: Deficits in adaptive immunity in the elderly. Tissue Antigens, 2007, 70, 179-189.
5. Busse, P.J.; Mathur, S.K. Age-related changes in immune function: Effect on airway inflammation. Allergy Clin Immunol., 2010, 126(4), 690-699.
6. Grubeck-Loebenstein, B.; Della Bella, S.; Iorio, A.M.; Michel, J.P.; Pawelec, G.; Solana, R. Immunosenescence and vaccine failure in the elderly. Aging Clin. Exp. Res., 2009, 21(3), 201-219
7. Rosato, E.; Salsano, F. Immunity, autoimmunity and autoimmune diseases in older people. J. Biol. Regul. Homeost. Agents, 2008, 22(4), 217-24
8. Wikby, A.; Månsson, I.A.; Johansson, B.; Strindhall, J.; Nilsson, S.E. The immune risk profile is associated with age and gender: Findings from three Swedish population studies of individuals 20-100 years of age. Biogerontology, 2008, 9(5), 299-308.
9. Larbi, A.; Franceschi, C.; Mazzatti, D.; Solana, R.; Wikby, A.; Pawelec, G. Aging of the immune system as a prognostic factor for human longevity. Physiology, 2008, 23, 64-74.
10. Gravekamp, C. Impact of aging on cancer vaccination. Curr. Opin. Immunol., 2011, 23, 555-560.
11. Derhovanessian, E.; Solana R.; Larbi, A.; Pawelec, G. Immunity, aging and cancer. Immun. Aging, 2008, Sep 24, 5, 11.
12. Malaguarnera, L.; Cristaldi, E.; Malaguarnera, M. The role of immunity in elderly cancer. Crit. Rev. Oncol. Hematol., 2010, 74(1), 40-60.
13. International Agency for Cancer Research: Globocan 2008 www.globocan.iarc.fr (Accessed March 6, 2012)
14. Clayton, D.; Schiffers, E. Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat. Med., 1987, 6, 469-481.
15. Peto, R.; Parish, S.E.; Gray, R.G. There is no such thing as aging, and cancer is not related to it. In: Likhacev A, Anisimov V, Montesano R, editors, IARC, Lyon, 1985, pp. 45-53.
16. Armitage, P.; Doll, R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer, 1961, 11, 161-169.
17. Day, N.E.; Brown, C.C. Multistage models in primary prevention of cancer. J. Natl. Cancer Inst., 1980, 64, 977-989.
18. Doll, R.; Peto, R. The causes of causes of cancer. Oxford, Oxford University Press, 1981.
19. Serraino, D.; Piselli, P.; Busnach, G.; Burra, P.; Citterio, F.; Arbustini, E.; Baccarani, U.; De Juli E.; Pozzetto, U.; Bellelli, S.; Polesel, J.; Pradier, C.; Dal Maso, L.; Angeletti, C.; Carrieri, M.P.; Rezza, G.; Franceschi, S. Immunosuppression and Cancer Study Group. Risk of cancer following immunosuppression in organ transplant recipients and in HIV positive individuals in southern Europe. Eur. J. Cancer, 2007, 43, 2117-2123.
20. Engels, E.; Pfeiffer, R.M.; Fraumeni, J.F. Jr; Kasiske, B.L.; Israni, A.K.; Snyder, J.J.; Wolfe, R.A.; Goodrich, N.P.; Bayakly, A.R.; Clarke, C.A.; Copeland, G.; Finch, J.L.; Fleissner, M.L.; Goodman, M.T.; Kahn, A.; Koch, L.; Lynch, C.F.; Madeleine, M.M.; Pawlish, K.; Rao, C.; Williams, M.A.; Castenson, D.; Curry, M.; Parsons, R.; Fant, G.; Lin, M. Spectrum of cancer risk among US solid organ transplant recipients. JAMA, 2011, 306, 1891-1901.
21. Shaw, A.C.; Joshi, S.; Greenwood, H.; Panda, A.; Lord, J.M. Aging of the innate immune system. Curr. Opin. Immunol., 2010, 22(4), 507-513.
22. Mauch, P.; Botnick, L.E.; Hannon, E.C.; Obbagy J.; Hellman S. Decline in bone marrow proliferative capacity as a function of age. Blood, 1982, 60(1), 245-252.
23. Liang, Y.; Van Zant, G.; Szilvassy, S.J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood, 2005, 106(4), 1479-1487.
24. Sudo, K.; Ema, H.; Morita, Y.; Nakauchi, H. Age-associated characteristics of murine hematopoietic stem cells. J. Exp. Med., 2000, 192(9), 1273-1280.
25. de Haan, G.; Nijhof, W.; Van Zant, G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: Correlation between lifespan and cycling activity. Blood, 1997, 89(5), 1543-1550.
26. Pang, W.W.; Price, E.A.; Sahoo, D.; Beerman, I.; Maloney, W.J.; Rossi, D.J.; Schrier, S.L.; Weissman, I.L. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl. Acad. Sci. USA, 2011, 108(50), 20012-20017.
27. Rossi, D.J.; Jamieson, C.H.; Weissman, I.L. Stems cells and the pathways to aging and cancer. Cell, 2008, 132(4), 681-696.
28. Rossi, D.J.; Bryder, D.; Seita, J.; Nussenzweig, A.; Hoeijmakers, J.; Weissman, I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature, 2007, 447(7145), 725-729.
29. Ju, Z.; Jiang, H.; Jaworski, M.; Rathinam, C.; Gompf, A.; Klein, C.; Trumpp, A.; Rudolph, K.L. Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat. Med., 2007, 13(6), 742-7.
30. Beerman, I.; Bhattacharya, D.; Zandi, S.; Sigvardsson, M.; Weissman, I.L.; Bryder, D.; Rossi, D.J. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl. Acad. Sci. USA, 2010, 107, 5465-5470.
31. Sauce, D.; Larsen, M.; Fastenackels, S.; Pauchard, M.; Ait-Mohand, H.; Schneider, L.; Guihot, A.; Boufassa, F.; Zaunders, J.; Iguertsira, M.; Bailey, M.; Gorochov, G.; Duvivier, C.; Carcelain, G.; Kelleher, A.D.; Simon, A.; Meyer, L.; Costagliola, D.; Deeks, S.G.; Lambotte, O.; Autran, B.; Hunt, P.W.; Katlama, K.; Appay, V. HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis. Blood, 2011, 117, 5142-5151.
32. Tempescul, A.; Ianotto, J.C.; Hardy, E.; Quivoron, F., Petroy, L., Berthou, C. Peripheral blood stem cell collection in elderly patients. Ann. Hematol., 2010, 89, 317, 21.
33. Beerman, I.; Maloney, W.J.; Weissmann, I.L.; Rossi, D.J. Stem cells and aging hematopoietic system. Curr. Opin. Immunol., 2010, 22, 500-506.
34. Zhang, N.; Bevan, M.J. CD8(+) T cells: Foot soldiers of the immune system. Immunity, 2011, 26, 35, 161-168.
35. De Rosa, S.C.; Herzenberg, L.A.; Herzenberg, L.A.; Roederer, M. 11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med., 2001, 7, 245-248.
36. De Rosa, S.C.; Brenchley, J.M.; Roederer, M. Beyond six colors: A new era in flow cytometry. Nat. Med., 2003, (1), 112-117.
37. von Andrian, U.H.; Mackay, C.R. T-cell function and migration. Two sides of the same coin. New Engl. J. Med., 2000, 343, 1020-1034.
38. Vallejo, A.N. CD28 extinction in human T cells: Altered functions and the program of T-cell senescence. Immunol Rev., 2005, 205, 158-169.
39. Saule, P.; Trauet, J.; Dutriez, V.; Lekeux, V.; Dessaint, J.; Labalette, M. Accumulation of memory T cells from childhood to old age: Central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech. Aging Dev., 2006, 127, 274-281.
40. Pfister, G.; Weiskopf, D.; Lazuardi, L.; Kovaiou, R.D.; Cioca, D.P.; Keller, M.; Lorbeg, B.; Parson, W.; Grubeck-Loebenstein, B. Naive T cells in the elderly: Are they still there? Ann. NY Acad. Sci., 2006, 1067, 152-157.
41. Naylor, K.; Li, G.; Vallejo, A.N.; Lee, W.W.; Koetz, K.; Bryl, E.; Witkowski, J.; Fulbright J.; Weyand, C.M.; Goronzy, J.J. The influence of age on T cell generation and TCR diversity. J. Immunol., 2005, 174(11), 7446-7452.
42. Gupta, S.; Gollapudi, S. TNF-alpha-induced apoptosis in human naïve and memory CD8 T cells in aged humans. Exp. Gerontol., 2006, 41(1), 69-77.
43. Gupta, S.; Gollapudi, S. CD95-mediated apoptosis in naïve, central and effector memory subsets of CD4+ and CD8+ T cells in aged humans. Exp. Gerontol., 2008, 43(4), 266-74.
44. Maue, A.C.; Haynes, L. CD4+ T cells and immunosenescence--a mini-review. Gerontology, 2009, 55, 491-495.
45. Arnold, C.R.; Wolf, J.; Brunner, S.; Herndler-Brandstetter, D.; Grubeck-Loebenstein, B. Gain and loss of T cell subsets in old age--age-related reshaping of the T cell repertoire. J. Clin. Immunol., 2011, 31(2), 137-46.
46. Herndler-Brandstetter, D; Veel E.; Laschober, G.T.; Pfister, G.; Brunner, S.; Walcher, S.; Parson, W.; Lepperdinger, G.; Grubeck-Loebenstein, B. Non-regulatory CD8+CD45RO+CD25+ T-lymphocytes may compensate for the loss of antigen-inexperienced CD8+CD45RA+ T-cells in old age. Biol. Chem., 2008, 389(5), 561-8.
47. Lazuardi, L.; Herndler-Brandstetter, D.; Brunner, S.; Laschober, G.T.; Lepperdinger, G.; Grubeck-Loebenstein, B. Microarray analysis reveals similarity between CD8+CD28-T cells from young and elderly persons, but not of CD8+CD28+ T cells. Biogerontology, 2009, 10(2), 191-202.
48. Garcia, G.G.; Miller, R.A. Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells. J. Immunol., 2002, 169, 5021-5027.
49. Swain, S.; Clise-Dwyer, K.; Haynes, L. Homeostasis and the age-associated defect of CD4 T cells. Semin. Immunol., 2005, 17(5), 370-377.
50. Clise-Dwyer, K.; Huston, G.E.; Buck, A.L.; Duso, D.K.; Swain, S.L. Environmental and intrinsic factors lead to antigen unresponsiveness in CD4(+) recent thymic emigrants from aged mice. J. Immunol., 2007, 178(3), 1321-31.
51. Maue, A.C.; Eaton, S.M.; Lanthier, P.A.; Sweet, K.B.; Blumerman, S.L.; Haynes, L. Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J. Immunol., 2009, 182(10), 6129-6135.
52. Messaoudi, I.; Warner, J.; Nikolich-Zugich, J. Age-related CD8 T cell clonal expansions express elevated levels of CD122 and CD127 and display defects in perceiving homeostatic signals. J. Immunol., 2006, 177(5), 2784-2792.
53. Messaoudi, I.; Lemaoult, J.; Guevara-Patino, J.A.; Metzner, B.M.; Nikolich-Zugich, J. Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense. J. Exp. Med., 2004, 200(10), 1347-58.
54. Brunner, S.; Herndler-Brandstetter, D.; Weinberger, B.; Grubeck-Loebenstein, B. Persistent viral infections and immune aging. Aging Res. Rev., 2011, 10(3), 362-369.
55. Sylwester, A.W.; Mitchell, B.L.; Edgar, J.B.; Taormina, C.; Pelte, C.; Ruchti, F.; Sleath, P.R.; Grabstein, K.H.; Hosken, N.A.; Kern, F.; Nelson, J.A.; Picker, L.J. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med., 2005, 202(5), 673-685.
56. Kober, J.; Leitner, J.; Klauser, C.; Woitek, R.; Majdic, O.; Stöckl, J.; Herndler-Brandstetter, D.; Grubeck-Loebenstein, B, Reipert, B.M.; Pickl, W.F.; Pfistershammer, K.; Steinberger, P. The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells. Eur. J. Immunol., 2008, 38(10), 2678-88.
57. Chiu, W.K.; Fann, M.; Wenig, N.P. Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J. Immunol., 2006, 177(11), 7802-7810.
58. Vallejo, A.N. Immune remodeling: Lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol. Med., 2007, 13(3), 94-102.
59. Hsu, H.C.; Scott, D.K.; Zhang, P.; Zhou, J.; Yang, P.; Wu, Q.; Schroeder, H.W. Jr; Gerald, L.B.; Ravussin, E.; Jazwinski, S.M.; Mountz, J.D.; Louisiana Healthy Aging Study. CD8 T-cell immune phenotype of successful aging. Mech. Aging Dev., 2006, 127(3), 231-239.
60. Pérez-Andres M.; Almeida, J.; Martin-Ayuso, M.; Moro, M.J.; Martin-Nuñez, G.; Galende, J.; Hernandez, J.; Mateo, G.; San Miguel, J.F.; Orfao, A.; Spanish Network on Multiple Myeloma; Spanish Network of Cancer Research Centers. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire. Cancer, 2006, 106(6), 1296-1305.
61. Arons, E.; Sorbara, L.; Raffeld, M.; Stetler-Stevenson, M.; Steinberg, S.M.; Liewehr, D.J.; Pastan, I.; Kreitman R.J. Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy. Cancer Immunol. Immunother., 2006, 55(9), 1100-1110.
62. Rezvany, M.R.; Jeddi-Tehrani, M.; Wigzell, H.; Osterborg, A.; Mellstedt, H. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood, 2003, 101(3), 1063-1070.
63. Walter, S.; Bioley, G.; Bühring, H.J.; Koch, S.; Wernet, D.; Zippelius, A.; Pawelec, G.; Romero, P.; Stevanovi, S.; Rammensee, H.G.; Gouttefangeas, C. High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors. Eur. J. Immunol., 2005, 35(10), 2876-2885.
64. Karanikas, V.; Zamanakou, M.; Soukou, F.; Kerenidi T.; Gourgoulianis, K.I.; Germenis, A.E. Naturally occurring tumor-specific CD8+ T-cell precursors in individuals with and without cancer. Immunol. Cell Biol., 2010, 88(5), 575-585.
65. Fülöp, T. Jr; Larbi, A.; Dupuis, G.; Pawelec, G. Aging, autoimmunity and arthritis: Perturbations of TCR signal transduction pathways with aging-a biochemical paradigm for the aging immune system. Arthritis Res. Ther., 2003, 5(6), 290-302.
66. Effros, R.B. Costimulatory mechanisms in the elderly. Vaccine, 2000, 18(16), 1661-1665.
67. Fulop, T.; Larbi, A.; Douziech, N.; Levesque, I.; Varin, A.; Herbein, G. Cytokine receptor signalling and aging. Mech. Aging Dev., 2006, 127(6), 526-537.
68. Cao, J.N.; Gollapudi, S.; Sharman, E.H.; Jia, Z.; Gupta, S. Age-related alterations of gene expression patterns in human CD8+ T cells. Aging Cell, 2010, 9(1), 19-31.
69. Onyema, O.O.; Njemini, R.; Bautmans, I.; Renmans, W.; De Waele, M.; Mets, T. Cellular aging and seescence characteristics of human T-lymphocytes. Biogerontology, 2011, Nov 19, Epub ahead of print.
70. Zhou, X.; McElhaney, J.E. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine, 2011, 29(11), 2169-2177.
71. Dock, J.N.; Effros, R.B. Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence. Aging Dis., 2011, 2(5), 382-397.
72. Lazuardi, L.; Jenewein, B.; Wolf, A.M.; Pfister, G.; Tzankov, A.; Grubeck-Loebenstein, B. Age-related loss of naïve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology, 2005, 114(1), 37-43.
73. Cheung, H.T.; Nadakavukaren, M.J. Age-dependent changes in the cellularity and ultrastructure of the spleen of Fischer F344 rats. Mech. Aging Dev., 1983, 22(1), 23-33.
74. Perez, S.D.; Silva, D.; Millar, A.B.; Molinaro, C.A.; Carter, J.; Bassett, K.; Lorton, D.; Garcia, P.; Tan, L.; Gross, J.; Lubahn, C.; Thyagarajan, S.; Bellinger, D.L. Sympathetic innervation of the spleen in male Brown Norway rats: A longitudinal aging study. Brain Res., 2009, 1302, 106-117.
75. Thyagarajan, S.; Madden, K.S.; Teruya, B.; Stevens, S.Y.; Felten, D.L.; Bellinger, D.L. Age-associated alterations in sympathetic noradrenergic innervation of primary and secondary lymphoid organs in female Fischer 344 rats. J. Neuroimmunol., 2011, 233(1-2), 54-64.
76. Bellinger, D.L.; Millar, B.A.; Perez, S.; Carter, J., Wood, C.; Thyagarajan, S.; Molinaro, C.; Lubahn, C.; Lorton, D. Sympathetic modulation of immunity: Relevance to disease. Cell. Immunol., 2008, 252, 27-56.
77. Pachówka, M.; Makula, J.; Korczak-Kowalska, G. Diminished cytokines gene expression in lymphoid organs of healthy aged rats. Cytokine, 2011, 54(1), 24-28.
78. Wang, L.; Xie, Y.; Zhu, L.J.; Chang, T.T.; Mao Y.Q.; Li, J. An association between immunosenescence and CD4(+)CD25(+) regulatory T cells: A systematic review. Biomed. Environ. Sci., 2010, 23, 327-332.
79. Chiu, B.C.; Stolberg, V.R.; Zhang, H.; Chensue, S.W. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice. Mech. Aging Dev., 2007, 128(11-12), 618-627.
80. Teng, M.W.; Ritchie, D.S.; Neeson, P.; Smyth, M.J. Biology and clinical observations of regulatory T cells in cancer immunology. Curr. Top Microbiol. Immunol., 2011, 344, 61-95.
81. De Paoli, P.; Gennari, D.; Reitano, M.; Martelli, P.; Sacilotto, C.; Comoretto, R.; Santini, G. CD8 lymphocytes during Epstein Barr virus (EBV) infection: A CD29 positive population is expanded in acute infectious mononucleosis. Allergol. Immunopathol. (Madr), 1991, 19(2), 95-97.
82. Hayday, A.C. A right time and a right place for a conserved third way of protection. Annu. Rev. Immunol., 2000, 18, 975-1026.
83. Mak, T.W.; Ferrick, D.A. The gammadelta T-cell bridge: Linking innate and acquired immunity. Nat. Med., 1998, 4(7), 764-765.
84. Argentati, K.; Re, F.; Donnini, A.; Tucci, M.G.; Franceschi, C.; Bartozzi, B.; Bernardini, G.; Provinciali, M. Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. J. Leukoc. Biol., 2002, 72(1), 65-71.
85. Giachino, C.; Granziero, L.; Modena, V.; Maiocco, V.; Lomater, C.; Fantini, F.; Lanzavecchia, A.; Migone, N. Clonal expansions of V delta 1+ and V delta 2+ cells increase with age and limit the repertoire of human gamma delta T cells. Eur. J. Immunol., 1994, 24(8), 1914-1918.
86. Yang, X.; Stedra, J.; Cerny, J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J. Exp. Med., 1996, 183(3), 959-970.
87. Johnson, S.A.; Cambier, J.C. Aging, autoimmunity and arthritis: Senescence of the B cell compartment-implications for humoral immunity. Arthritis Res. Ther., 2004, 6(4), 131-139.
88. Weksler, M.E. Changes in the B-cell repertoire with age. Vaccine, 2000, 18(16), 1624-1628.
89. Gayoso, I.; Sanchez-Correa, B.; Campos, C.; Alonso, C.; Pera, A.; Casado, J.G.; Morgado, S.; Tarazona, R.; Solana, R. Immunosenescence of human natural killer cells. J. Innate Immun., 2011, 3(4), 337-343.
90. Borrego, F.; Alonso, M.C.; Galiani, M.D.; Carracedo, J.; Ramirez, R.; Ostos, B.; Peña, J.; Solana, R. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp. Gerontol., 1999, 34(2), 253-265.
91. Bender, B.S.; Chrest, F.J.; Adler, W.H. Phenotypic expression of natural killer cell associated membrane antigens and cytolytic function of peripheral blood cells from different aged humans. J. Clin. Lab. Immunol., 1986, 21(1), 31-36.
92. Provinciali, M.; Di Stefano, G.; Fabris, N. Evaluation of lymphokine-activated killer cell development in young and old healthy humans. Nat. Immun., 1995, 14(3), 134-144.
93. Fabris, N.; Mocchegiani, E.; Provinciali, M. Plasticity of neuroendocrine-thymus interactions during aging. Exp. Gerontol., 1997, 32(4-5), 415-429.
94. Mariani, E.; Neri, S.; Cattini, L.; Mocchegiani, E.; Malavolta, M.; Dedoussis, G.V.; Kanoni, S.; Rink, L.; Jajte, J.; Facchini, A. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: Interactive influence of +647 MT1a and-174 IL-6 polymorphic alleles. Exp. Gerontol., 2008, 43(5), 462-471.
95. Provinciali, M.; Di Stefano, G.; Stronati, S.; Fabris, N. Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients. Cytokine, 1998, 10(2),132-139.
96. Hashimoto, D.; Miller, J.; Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity, 2011, 35(3), 323-335.
97. Sadeghi, H.M.; Schnelle, J.F.; Thoma, J.K.; Nishanian, P.; Fahey, J.L. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp. Gerontol., 1999, 34(8), 959-970.
98. Mishto, M.; Santoro, A.; Bellavista, E.; Bonafé, M.; Monti, D.; Franceschi, C. Immunoproteasomes and immunosenescence. Aging Res. Rev., 2003, 2(4), 419-432.
99. Khare, V.; Sodhi, A.; Singh, S.M. Effect of aging on the tumoricidal functions of murine peritoneal macrophages. Nat. Immun., 1996-1997, 15(6), 285-294.
100. Agrawal, A.; Agrawal, A.; Tay, J.; Gupta, S.; Biology of dendritic cells in aging. J. Clin. Immunol., 2008, 28, 14-20.
101. Steger, M.M.; Maczek, C.; Grubeck-Loebenstein, B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin. Exp. Immunol., 1996, 105(3), 544-550.
102. Della Bella, S.; Bierti, L.; Presicce, P.; Arienti, R.; Valenti, M.; Saresella, M.; Vergani, C.; Villa, M.L. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol., 2007, 122(2), 220-228.
103. Agrawal, A.; Agrawal, S.; Cao, J.N.; Su, H.; Osann, K.; Gupta, S. Altered innate immune functioning of dendritic cells in elderly humans: A role of phosphoinositide 3-kinase-signaling pathway. J. Immunol., 2007, 178(11), 6912-6922.
104. Del Prete, A.; Vermi, W.; Dander, E.; Otero, K.; Barberis, L.; Luini, W.; Bernasconi, S.; Sironi, M.; Santoro, A.; Garlanda, C.; Facchetti, F.; Wymann. M.P.; Vecchi, A.; Hirsch, E.; Mantovani, A.; Sozzani, S. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice. EMBO J., 2004, 23(17), 3505-3515.
105. Agrawal, A.; Tay, J.; Ton, S.; Agrawal, S.; Gupta, S. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J. Immunol., 2009, 182(2), 1138-1145.
106. Bonafè, M.; Storci, G.; Franceschi, C. Inflamm-aging of the stem cell niche: Breast cancer as a paradigmatic example: Breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays, 2012, 34(1), 40-49.
107. Franceschi, C.; Bonafè, M.; Valensin, S.; Olivieri, F.; De Luca, M.; Ottaviani, E.; De Benedictis, G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY Acad. Sci., 2000, 908, 244-254.
108. Maggio, M.; Guralnik, J.M.; Longo, D.L.; Ferrucci, L. Interleukin-6 in aging and chronic disease: A magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci., 2006, 61(6), 575-584.
109. Kamimura, D.; Ishihara, K.; Hirano, T. IL-6 signal transduction and its physiological roles: The signal orchestration model. Rev Physiol Biochem Pharmacol., 2003, 149, 1-38.
110. Brüünsgaard, H.; Pedersen, B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am., 2003, 23(1), 15-39.
111. Wikby, A.; Nilsson, B.; Forsey, R.; Thompson, J.; Strindhall, J.; Lofgren, S.; Ernerudh, J.; Pawelec, G.; Ferguson, F.; Johansson, B. The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Aging Dev., 2006, 127, 695-704.
112. Shearer, G.M. Th1/Th2 changes in aging. Mech Aging Dev., 1997, 94(1-3), 1-5.
113. Fulop, T.; Kotb, R.; Fortin, C.F.; Pawelec, G.; de Angelis, F.; Larbi, A. Potential role of immunosenescence in cancer development. Ann. N. Y. Acad. Sci., 2010, 1197, 158-165.
114. Hamilton, D.H.; Bretscher, P.A. Different immune correlates associated with tumor progression and regression: Implications for prevention and treatment of cancer. Cancer Immunol. Immunother., 2008, 57(8), 1125-1136.
115. Fried, S.K.; Bunkin, D.A.; Greenberg, A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab., 1998, 83(3), 847-850.
116. Gregor, M.F.; Hotamisligil, G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol., 2011, 29, 415-445.
117. Tilg, H.; Moschen, A.R. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol., 2006, 6(10), 772-783.
118. Gouin, J.P.; Hantsoo, L.; Kiecolt-Glaser, J.K. Immune dysregulation and chronic stress among older adults: A review. Neuroimmunomodulation, 2008, 15(4-6), 251-259.
119. Biagi, E.; Nylund, L.; Candela, M.; Ostan, R.; Bucci, L.; Pini, E.; Nikkïla, J.; Monti, D.; Satokari, R.; Franceschi, C.; Brigidi, P.; De Vos, W. Through aging, and beyond: Gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 2010, 5(5), e10667.
120. Malaguarnera, G.; Leggio, F.; Vacante, M.; Motta, M.; Giordano, M.; Biondi, A.; Basile, F.; Mastrojeni, S.; Mistretta, A.; Malaguarnera, M.; Toscano, M.; Salmeri M. Probiotics in the gastrointestinal diseases of the elderly. The J. Nutr. Health Aging, 2012, 16, 402-410.
121. Fukushima, Y. Improvement of nutritional status and incidence of infection in hospitalized, enterally feed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsoni La1. Br. J. Nutr., 2007, 98, 969-977.
122. Topping, DL. Short chain fatty acids produced by intestinal bacteria. Asia pacific J. Clin. Nutr., 1996, 5, 15-19.
123. Martin G.M. The biology of aging: 1985-2010 and beyond. FASEB J., 2011, 25(11), 3756-3762.
124. Naumova, E.; Ivanova, M.; Pawelec, G.; Constantinescu, I.; Bogunia-Kubik, K.; Lange, A.; Qguz, F.; Carin, M.; Franceschi, C.; Caruso, C.; Middleton, D. 'Immunogenetics of Aging': Report on the activities of the 15th International HLA and Immunogenetics Working Group and 15th International HLA and Immunogenetics Workshop. Tissue Antigens, 2011, 77(3), 187-192.
125. Gameiro, C.; Romao, F. Changes in the immune system during menopause and aging. Front. Biosci. (Elite Ed), 2010, 2, 1299-1303.
126. Goetzl, E.J.; Huang, M.C.; Kon, J.; Patel, K.; Schwartz, J.B.; Fast, K.; Ferrucci, L.; Madara, K.; Taub, D.D.; Longo, D.L. Gender specificity of altered human immune cytokine profiles in aging. FASEB J., 2010, 24(9), 3580-3589.
127. Kim, H.O.; Kim, H.S.; Youn, J.C.; Shin, E.C.; Park, S. Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J. Transl. Med., 2011, 9, e113.
128. Naugler, W.E.; Sakurai, T.; Kim, S.; Maeda, S.; Kim, K.; Elsharkawy, A.M.; Karin, M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 2007, 317(5834), 121-124.
129. Lawrence, T.; Hagemann, T.; Balkwill, F. Sex, Cytokines, and Cancer. Science, 2007, 317(5834), 51-52.
130. Heikkilä, K.; Ebrahim, S.; Lawlor, D.A. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur. J. Cancer, 2008, 44(7), 937-945.
131. Caruso, C.; Candore, G.; Colonna Romano, G.; Lio, D.; Bonafè, M.; Valensin, S.; Franceschi C. HLA, aging, and longevity: A critical reappraisal. Hum. Immunol., 2000, 61(9), 942-949.
132. Ershler, W.B.; Keller, E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med., 2000, 51, 245-270.
133. Lio, D.; Scola, L.; Crivello, A.; Colonna-Romano, G.; Candore, G.; Bonafè, M.; Cavallone, L.; Franceschi, C.; Caruso C. Gender-specific association between-1082 IL-10 promoter polymorphism and longevity. Genes Immun., 2002, 3(1), 30-33.
134. Bonafè, M.; Olivieri, F.; Cavallone, L.; Giovagnetti, S.; Mayegiani, F.; Cardelli, M.; Pieri, C.; Marra, M.; Antonicelli, R.; Lisa, R.; Rizzo, M.R.; Paolisso, G.; Monti, D.; Franceschi, C. A gender--dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol., 2001, 31(8), 2357-2361.
135. Franceschi, C.; Capri, M.; Monti, D.; Giunta, S.; Olivieri, F.; Sevini, F.; Panourgia, M.P.; Invidia, L.; Celani, L.; Scurti, M.; Cevenini, E.; Castellani, G.C.; Salvioli, S. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech. Aging Dev., 2007, 128(1), 92-105.
136. Derhovanessian, E.; Maier, A.B.; Beck, R.; Jahn, G.; Hahnel, K.; Slagboom, P.E.; de Craen, A.J.M.; Westendorp, R.G.J. Pawelec, G. Hallmark features of immunosenescence are absent in familial longevity. J. Immunol., 2010, 158, 4618-4624.
137. Balistreri, C.R.; Candore, G.; Colonna-Romano, G.; Lio, D.; Caruso, M.; Hoffmann E.; Franceschi, C.; Caruso, C. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA, 2004, 292(19), 2339-2340.
138. Sansoni, P.; Vescovini, R.; Fagnoni, F., Biasini, C., Zanni, F.; Zanlari, L.; Telera, A., Lucchini, G., Passeri, G.; Monti, D.; Franceschi, C.; Passeri, M. The immune system in extreme longevity. Exp. Gerontol., 2008, 43, 61-65.
139. Sansoni, P.; Fagnoni F.; Vescovini, R.; Mazzola, M.; Brianti, V.; Bologna, G.; Nigro, E.; Lavagetto, G.; Cossarizza, A.; Monti, D.; Franceschi, C.; Passeri M. T lymphocyte proliferative capability to defined stimuli and costimulatory CD28 pathway is not impaired in healthy centenarians. Mech. Aging Dev., 1997, 96(1-3), 127-136.
140. Marttila, S.; Jylhävä, J.; Pesu, M.; Hämäläinen, S.; Jylhä, M.; Hervonen, A.; Hurme, M. IL-7 concentration is increased in nonagenarians but is not associated with markers of T cell immunosenescence. Exp. Gerontol., 2011, 46(12), 1000-1002.
141. Bonafè, M.; Barbi, C.; Storici, G.; Salvioli, S.; Capri, M.; Olivieri, F., Valensin, S.; Monti, D., Gonos, E.S.; De Benedictis, G.; Franceschi, C. What studies on human longevity tell us about the risk for cancer in the oldest old: Data and hypotheses on the genetics and immunology of centenarians. Exp. Gerontol., 2002, 37, 1263-1271.
142. Salvioli, S.; Bonafé, M.; Barbi, C.; Storci, G.; Trapassi, C.; Tocco, F.; Gravina, S.; Rossi, M.; Tiberi, L.; Mondello, C.; Monti, D.; Franceschi, C. p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1. Cell Cycle, 2005, 4(9), 1264-1271.
143. Andersen, S.L.; Terry, D.F.; Wilcox, M.A.; Babineau, T.; Malek, K.; Perls, T.T. Cancer in the oldest old. Mech. Aging Dev., 2005, 126(2), 263-267.
144. Salvioli, S.; Capri, M.; Bucci, L.; Lanni, C.; Racchi, M.; Uberti, D.; Memo, M.; Mari, D.; Govoni, S.; Franceschi, C. Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol. Immunother., 2009, 58(12), 1909-1917.
145. Stanta, G.; Campagner, L.; Cavallieri, F.; Giarelli, L. Cancer of the oldest old. What we have learned from autopsy studies. Clin. Geriatr. Med., 1997, 13(1), 55-68.
146. Dunn, G.P.; Bruce, A.T.; Ikeda, H.; Old, LJ; Schreiber, RD. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol., 2002, 3(11), 991-998.
147. Schreiber, R.D.; Old, L.J.; Smyth, M.J. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science, 2011, 331(6024), 1565-1570.
148. Prestwich, R.J.; Errington, F.; Hatfield, P.; Merrick, A.E.; Ilett, E.J.; Selby, P.J.; Melcher, A.A. The immune system--is it relevant to cancer development, progression and treatment? Clin. Oncol., 2008, 20(2), 101-112.
149. Aw, D.; Silva, A.B.; Palmer, D.B. Immunosenescence: Emerging challenges for an aging population. Immunology, 2007, 120(4), 435-446.
150. Gravekamp, C.; Sypniewska, R.; Hoflack, L. The usefulness of mouse breast tumor models for testing and optimization of breast cancer vaccines at old age. Mech. Aging Dev., 2004, 125(2), 125-127.
151. Gravekamp, C. Tailoring cancer vaccines to the elderly: The importance of suitable mouse models. Mech. Aging Dev., 2001, 122(11), 1087-1105.
152. Kaesberg, P.R.; Ershler, W.B. The change in tumor aggressiveness with age: Lessons from experimental animals. Semin. Oncol., 1989, 16(1), 28-33.
153. Fulop, T.; Larbi, A.; Kotb, R.; de Angelis, F.; Pawelec, G. Aging, immunity, and cancer. Discov Med., 2011, 11(61), 537-550.
154. Wherry, E.J. T cell exhaustion. Nat. Immunol., 2011, 12(6), 492-499.
155. Gooden, M.J.; de Bock, G.H.; Leffers, N.; Daemen, T.; Nijman, H.W. The prognostic influence of tumour-infiltrating lymphocytes in cancer: A systematic review with meta-analysis. Br. J. Cancer, 2011, 105(1), 93-103.
156. Ferrarini, M.; Ferrero, E.; Dagna, L.; Poggi, A.; Zocchi, M.R. Human gammadelta T cells: A nonredundant system in the immune-surveillance against cancer. Trends Immunol., 2002, 23(1),14-18.
157. Boismenu, R.; Feng, L.; Xia, Y.Y.; Chang, J.C.; Havran, W.L. Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J. Immunol., 1996, 157(3), 985-992.
158. Fricke, I.; Gabrilovich, D.I. Dendritic cells and tumor microenvironment: A dangerous liaison. Immunol. Invest., 2006, 35(3-4), 459-483.
159. Do, J.; Visperas, A.; Oh, K.; Stohlman, S.A.; Min, B. Memory CD4 T cells induce selective expression of IL-27 in CD8+ dendritic cells and regulate homeostatic naive T cell proliferation. J. Immunol., 2012, 188(1), 230-237.
160. Stary, G.; Bangert, C.; Tauber, M.; Strohal, R.; Kopp, T.; Stingl, G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J. Exp. Med., 2007, 204(6), 1441-1451.
161. Pinzon-Charry, A.; Maxwell, T.; López, J.A. Dendritic cell dysfunction in cancer: A mechanism for immunosuppression. Immunol. Cell. Biol., 2005, 83(5), 451-461.
162. Shurin, M.R.; Shurin, G.V.; Lokshin, A.; Yurkovetsky, Z.R.; Gutkin, D.W.; Chatta, G.; Zhong, H.; Han, B.; Ferris, R.L. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: Friends or enemies? Cancer Metastasis Rev., 2006, 25(3), 333-356.
163. Kusmartsev, S.; Gabrilovich, D.I. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Rev., 2006, 25(3), 323-331.
164. Scarlett, U.K.; Rutkowski, M.R.; Rauwerdink, A.M.; Fields, J.; Escovar-Fadul, X.; Baird, J.; Cubillos-Ruiz, J.R.; Jacobs, A.C.; Gonzalez, J.L.; Weaver, J.; Fiering, S.; Conejo-Garcia, J.R. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J. Exp. Med., 2012, Feb 20. [Epub ahead of print]
165. Ostrand-Rosenberg, S. Immune surveillance: A balance between protumor and antitumor immunity. Curr. Opin. Genet. Dev., 2008, 18(1), 11-18.
166. Zitvogel, L.; Kepp, O.; Kroemer, G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat. Rev. Clin. Oncol., 2011, 8(3), 151-160.
167. Kepp, O.; Galluzzi, L.; Martins, I.; Schlemmer, F.; Adjemian, S.; Michaud, M.; Sukkurwala, A.Q.; Menger, L.; Zitvogel, L.; Kroemer, G. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev., 2011, 30(1), 61-69.
168. Ma, Y.; Conforti, R.; Aymeric, L.; Locher, C.; Kepp, O.; Kroemer, G.; Zitvogel, L. How to improve the immunogenicity of chemotherapy and radiotherapy. Cancer Metastasis Rev., 2011, 30(1), 71-82.
169. Motta, M.; Ferlito, L.; Malaguarnera, L.; Vinci, E.; Bosco, S.; Maugeri, D.; Malaguarnera, M. Alterations of the lymphocytic set-up in elderly patients with cancer. Arch. Gerontol. Geriatr., 2003, 36(1), 7-14.
170. Disis, M.L. Immune regulation of Cancer. J. Clin. Oncol., 2010, 28, 4531-4538.
171. Pawelec, G.; Heinzel, S.; Kiessling, R.; Müller, L.; Ouyang, Q.; Zeuthen, J. Escape mechanisms in tumor immunity: A year 2000 update. Crit. Rev. Oncog., 2000, 11(2), 97-133.
172. Wolf, A.M.; Wolf, D.; Steurer, M.; Gastl, G.; Gunsilius, E.; Grubeck-Loebenstein, B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res., 2003, 9(2), 606-612.
173. Chen, K.J.; Lin, S.Z.; Zhou, L.; Xie, H.Y.; Zhou, W.H.; Taki-Eldin, A.; Zheng, S.S. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One, 2011, 6(9), e24671.
174. Curiel, T.J.; Coukos, G.; Zou, L.; Alvarez, X.; Cheng, P.; Mottram, P.; Evdemon-Hogan, M.; Conejo-Garcia, J.R.; Zhang, L.; Burow, M.; Zhu, Y.; Wei, S.; Kryczek, I.; Daniel, B.; Gordon, A.; Myers, L.; Lackner, A.; Disis, M.L.; Knutson, K.L.; Chen, L.; Zou, W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med., 2004, 10(9), 942-949.
175. Widén, K.; Mozaffari, F.; Choudhury, A.; Mellstedt, H. Overcoming immunosuppressive mechanisms. Ann. Oncol., 2008, 19 Suppl 7, vii241-247.
176. Olkhanud, P.B.; Baatar, D.; Bodogai, M.; Hakim, F.; Gress, R.; Anderson, R.L.; Deng, J.; Xu, M.; Briest, S.; Biragyn, A. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res., 2009, 69(14), 5996-6004.
177. Olkhanud, P.B.; Damdinsuren, B.; Bodogai, M.; Gress, R.E.; Sen, R.; Wejksza, K.; Malchinkhuu, E.; Wersto, R.P.; Biragyn, A. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 T cells to T-regulatory cells. Cancer Res., 2011, 71(10), 3505-3512.
178. Kiertscher, S.M.; Luo, J.; Dubinett, S.M.; Roth, M.D. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol., 2000, 164(3), 1269-1276.
179. Bell, D.; Chomarat, P.; Broyles, D.; Netto, G.; Harb, G.M.; Lebecque, S.; Valladeau, J.; Davoust, J.; Palucka, K.A.; Banchereau, J. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med., 1999, 190(10), 1417-1426.
180. Kim, R.; Emi, M.; Tanabe, K.; Arihiro, K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res., 2006, 66(11), 5527-5536.
181. Gottfried, E.; Kreutz, M.; Mackensen, A. Tumor-induced modulation of dendritic cell function. Cytokine Growth Factor Rev., 2008, 19(1),65-77.
182. Poggi, A.; Zocchi, M.R. Mechanisms of tumor escape: Role of tumor microenvironment in inducing apoptosis of cytolytic effector cells. Arch. Immunol. Ther. Exp. (Warsz), 2006, 54(5), 323-333.
183. Webb, S.D.; Sherratt, J.A.; Fish, R.G. Cells behaving badly: A theoretical model for the Fas/FasL system in tumour immunology. Math. Biosci., 2002, 179(2), 113-129.
184. Doubrovina ES; Doubrovin MM; Vider, E.; Sisson, R.B.; O'Reilly, R.J; Dupont B; Vyas Y.M. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J. Immunol., 2003, 171(12), 6891-6899.
185. Saijo, Y.; Tanaka, M.; Miki, M.; Usui, K.; Suzuki, T.; Maemondo, M.; Hong, X.; Tazawa, R.; Kikuchi, T.; Matsushima, K.; Nukiwa, T. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: In vivo analysis of tumor-stromal interaction. J. Immunol., 2002, 169(1), 469-475.
186. Mocellin, S.; Rossi C.R.; Pilati, P.; Nitti, D. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev., 2005, 16(1), 35-53.
187. Zhou, D.; Chrest, F.J.; Adler, W.; Munster, A.; Winchurch, R.A. Increased production of TGF-beta and Il-6 by aged spleen cells. Immunol Lett., 1993, 36(1), 7-11.
188. Trinchieri, G. Innate inflammation and cancer: Is it time for cancer prevention? F1000 Medicine Reports, 2011, 3, 11-16.
189. Tsavaris, N.; Kosmas, C.; Vadiaka, M.; Kanelopoulos, P.; Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer, 2002, 87(1), 21-27.
190. Komada, Y.; Zhang, S.L.; Zhou, Y.W.; Hanada, M.; Shibata, T.; Azuma, E.; Sakurai, M. Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy. Cancer Immunol Immunother., 1992, 35(4), 271-276.
191. Mackall, C.L.; Fleisher, T.A.; Brown, M.L., Andrich, M.P.; Chen, C.C.; Feuerstein, I.M.; Horowitz, M.E.; Megrath, I.T.; Shad, A.T.; Steinberg, S.M. et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med., 1995, 332, 143-149.
192. Simonelli, C.; Tedeschi, R.; Gloghini, A.; Bortolin, M.T.; Spina, M.; Bidoli, E.; Cinelli R.; De Paoli P.; Carbone, A.; Tirelli, U. Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy. Clin. Infect. Dis., 2005, 40(7), 1022-1027.
193. Simonelli, C.; Zanussi, S.; Pratesi, C.; Rupolo, M.; Bortolin M.T.; Talamini, R.; Caffau, C.; Tedeschi, R.; Basaglia, G.; Mazzucato, M.; Manuele, R.; Vaccher E.; Spina, M.; Tirelli, U.; Michieli, M.; De Paoli, P. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Clin. Infect. Dis., 2010, 50(12), 1672-1679.
194. van Tilburg, C.M.; van Gent, R.; Bierings, M.B.; Otto, S.A.; Sanders, E.A.; Nibbelke, E.E.; Gaiser, J.F.; Janssens-Korpela, P.L.; Wolfs, T.F.; Bloem, A.C.; Borghans, J.A.; Tesselaar, K. Immune reconstitution in children following chemotherapy for haematological malignancies: A long-term follow-up. Br. J. Haematol., 2011, 152(2), 201-210.
195. Williams, K.M.; Hakim, F.T.; Gress, R.E. T cell immune reconstitution following lymphodepletion. Semin. Immunol., 2007, 19(5), 318-330.
196. Isaacs, J.D.; Thiel, A. Stem cell transplantation for autoimmune disorders. Immune reconstitution. Best Pract. Res. Clin Haematol., 2004, 17(2), 345-358.
197. Mariucci, S.; Rovati, B.; Manzoni, M.; Della Porta, M.G.; Comolli, G.; Delfanti, S.; Danova, M. Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors. Clin. Exp. Med., 2011, 11(4), 199-210.
198. Mackall, C.L.; Fleisher, T.A.; Brown, M.R.; Andrich, M.P.; Chen, C.C.; Feuerstein, I.M.; Magrath, I.T.; Wexler, L.H.; Dimitrov, D.S.; Gress, R.E. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood, 1997, 89(10), 3700-3707.
199. Murphy, W.J.; Artz, A.S.; Champlin, R.E.; Koreth, J.; Longo D.L.; van den Brink, M.R. Blood stem cell transplantation in older patients. Biol. Blood Marrow Transplant., 2009, 15(12), 1638-1639.
200. rd; Cutler, C.; Armand, P.; Ritz, J.; Antin, J.H.; Soiffer, R.J.; Ho, V.T. Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: Hematologic malignancy outcomes are not impaired in advanced age. Biol. Blood Marrow Transplant., 2010, 16(6), 792-800.
201. Cohen, Y.C.; Scaradavou, A.; Stevens, C.E.; Rubinstein, P.; Gluckman, E.; Rocha, V.; Horowitz, M.M.; Eapen, M.; Nagler, A.; Shpall, E.J.; Laughlin, M.J.; Daniely, Y.; Pacheco, D.; Barishev, R.; Olmer, L.; Freedman, L.S. Factors affecting mortality following myeloablative cord blood transplantation in adults: A pooled analysis of three international registries. Bone Marrow Transplant., 2011, 46(1), 70-76.
202. Hakim, F.T.; Flomerfelt, F.A.; Boyiadzis, M.; Gress, R.E. Aging, immunity and cancer. Curr. Opin. Immunol., 2004, 16(2), 151-156.
203. Rosenberg, S.A.; Yang, J.C. Restifo, N.P. Cancer immunotherapy: Moving beyond current vaccines. Nat. Med., 2004, 10(9), 909-915.
204. Gravekamp, C.; Sypniewska, R.; Gauntt, S.; Tarango, M.; Price, P.; Reddick, R. Behavior of metastatic and nonmetastatic breast tumors in old mice. Exp. Biol.Med. (Maywood), 2004, 229(7), 665-675.
205. Provinciali, M.; Argentati, K.; Tibaldi, A. Efficacy of cancer gene therapy in aging: Adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. Gene Ther., 2000, 7(7), 624-632.
206. Sharma, S.; Dominguez, A.L.; Hoelzinger, D.B.; Lustgarten, J. CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: The implications for vaccinations in the aged. Cancer Immunol. Immunother., 2008, 57(4), 549-561.
207. Lustgarten, J.; Dominguez, A.L.; Thoman, M. Aged mice develop protective antitumor immune responses with appropriate costimulation. J. Immunol., 2004, 173(7), 4510-4515.
208. Sharma, S.; Dominguez, A.L.; Lustgarten, J. Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp. Gerontol., 2006, 41(1), 78-84.
209. Tan, J.T.; Dudl, E.; LeRoy, E.; Murray, R.; Sprent, J.; Weinberg, K.I.; Surh, C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA, 2001, 98(15), 8732-8737.
210. Sportès, C.; Babb, R.R.; Krumlauf, M.C.; Hakim, F.T.; Steinberg, S.M.; Chow, C.K.; Brown, M.R.; Fleisher, T.A.; Noel, P.; Maric, I.; Stetler-Stevenson, M.; Engel, J.; Buffet, R.; Morre, M.; Amato, R.J.; Pecora, A.; Mackall, C.L.; Gress, R.E. Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin. Cancer Res., 2010, 16(2), 727-735.
211. Dannull, J.; Su, Z.; Rizzieri, D.; Yang, B.K.; Coleman, D.; Yancey, D.; Zhang, A.; Dahm, P.; Chao, N.; Gilboa, E.; Vieweg, J. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest., 2005, 115(12), 3623-3633.
212. Ruter, J.; Barnett, B.G.; Kryczek, I.; Brumlik, M.J.; Daniel, B.J.; Coukos, G.; Zou, W.; Curiel, T.J. Altering regulatory T cell function in cancer immunotherapy: A novel means to boost the efficacy of cancer vaccines. Front. Biosci., 2009, 14, 1761-1770.
213. Kusmartsev, S.; Su, Z.; Heiser, A.; Dannull, J.; Eruslanov, E.; Kübler, H.; Yancey, D.; Dahm P.; Vieweg, J. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin. Cancer Res., 2008, 14(24), 8270-8278.
214. Montrone, M.; Martorelli, D.; Rosato, A.; Dolcetti, R: Retinoids as critical modulators of immune functions: New therapeutic perspectives for old compounds. Endocr. Metab. Immune Disord. Drug Targets, 2009, 9 (2), 113-131.
215. Nefedova, Y.; Fishman, M.; Sherman, S.; Wang, X.; Beg, A.A.; Gabrilovich, D.I. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res., 2007, 67(22), 11021-11028.
216. Sharma, P.; Wagner, K.; Wolchok, J.D.; Allison, J.P. Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps. Nat. Rev. Cancer, 2011, 11(11), 805-812.
217. Lipson, E.J. Drake, C.G. Ipilimumab: An anti-CTLA-4 antibody for metastatic melanoma. Clin. Cancer Res., 2011, 17(22), 6958-6962.
218. Kim, S.H.; Castro, F.; Paterson, Y.; Gravekamp, C. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res., 2009, 69(14), 5860-5866.
219. Giaccone, G.; Punt, C.J.; Ando, Y.; Ruijter, R.; Nishi, N.; Peters, M.; von Blomberg, B.M.; Scheper, R.J.; van der Vliet, H.J.; van den Eertwegh, A.J.; Roelvink, M.; Beijnen, J.; Zwierzina, H.; Pinedo, H.M. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res., 2002, 8(12), 3702-3709.
220. Hirokawa, K.; Utsuyama, M.; Ishikawa, T.; Kikuchi, Y.; Kitagawa, M.; Fujii, Y.; Nariuchi, H.; Uetake, H.; Sugihara, K. Decline of T cell-related immune functions in cancer patients and an attempt to restore them through infusion of activated autologous T cells. Mech. Aging Dev., 2009, 130(1-2), 86-91.
221. Stemberger, C.; Huster, K.M.; Koffler, M.; Anderl, F.; Schiemann, M.; Wagner, H.; Busch, D.H. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity, 2007, 27(6), 985-997.
222. Buchholz, V.R.; Neuenhahn, M.; Busch, D.H. CD8+ T cell differentiation in the aging immune system: Until the last clone standing. Curr. Opin. Immunol., 2011, 23(4), 549-554.
223. Germenis, A.E.; Karanikas, V. Cord blood as a source of non-senescent lymphocytes for tumor immunotherapy. J. Reprod. Immunol., 2010, 85(1), 47-50.
224. Azuma, H.; Yamada, Y.; Shibuya-Fujiwara, N.; Yamaguchi, M.; Murahashi, H.; Fujihara, M.; Sato, N.; Fukazawa, K.; Ikebuchi, K.; Ikeda, H. Functional evaluation of ex vivo expanded cord blood lymphocytes: Possible use for adoptive cellular immunotherapy. Exp. Hematol., 2002, 30(4), 346-351.
225. Lu, X.C.; Yang, B.; Yu, R.L.; Chi, X.H.; Tuo, S.; Tuo, C.W.; Zhu, H.L.; Wang, Y.; Jiang, C.G.; Fu, X.B.; Yang, Y.; Liu, Y.; Yao, S.Q.; Dai, H.R.; Cai, L.L.; Li, B.J.; Han, W.D. Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma. Cell. Biochem. Biophys., 2012, 62(1), 257-265.
226. Janetzki, S.; Britten, C.M.; Kalos, M.; Levitsky, H.I.; Maecker, H.T.; Melief, C.J.; Old, L.J.; Romero, P.; Hoos, A.; Davis, M.M. MIATA-minimal information about T cell assays. Immunity, 2009, 31(4), 527-528.
227. van der Burg, S.H.; Kalos, M.; Gouttefangeas, C.; Janetzki, S.; Ottensmeier, C.; Welters, M.J.; Romero, P.; Britten, C.M.; Hoos, A. Harmonization of immune biomarker assays for clinical studies. Sci. Transl. Med., 2011, 3(108), 108ps44.
228. Davis, M. A prescription for human immunology. Immunity, 2008, 29, 835-838.
229. Ligthart, G.H. The SENIEUR protocol after 16 years: The next step is to study the interaction of aging and disease. Mech. Aging Dev., 2001, 122(2), 136-140.